Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Famotidine effect on Atazanavir PK in HIV
NCT01232127Phase 4Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Feb 2011
- Primary completion
- Jun 2011
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 4 trial of atazanavir in human immunodeficiency virus infection (HIV), sponsored by Bristol Myers Squibb. Started Feb 2011; status: completed.
02
Drugs
atazanavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT01232127.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01232127.